Amalgamated Bank’s SBC Medical Group SBC Stock Holding History

Amalgamated Bank’s Portfolio SBC Stock Details SBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-354	Closed	-$2K	–	2888
2025 Q4	$2K	Buy	354 +161	+83%	+$614	﹤0.01%	2929
2025 Q3	$1K	Hold	193	–	–	﹤0.01%	2985
2025 Q2	$1K	Buy	+193	New	+$763	﹤0.01%	3007

Other funds holding SBC

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VFT

Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Amalgamated Bank's SBC Position: Q1 2026 in Review

Amalgamated Bank sold out of SBC Medical Group (SBC) in Q1 2026, closing a stake of 354 shares — an estimated $2K sold.

Amalgamated Bank first reported a position in SBC in Q2 2025 and held it in 3 quarters. The position peaked at $2K in Q4 2025. 50 funds tracked by Wall St. Rank hold SBC as of Q1 2026.

Amalgamated Bank reported no remaining SBC Medical Group position as of Q1 2026 after selling out during the quarter.
Amalgamated Bank sold 354 SBC Medical Group shares in Q1 2026, an estimated $2K.
Amalgamated Bank first reported a position in SBC Medical Group in Q2 2025 and held it in 3 quarters.
Amalgamated Bank's SBC Medical Group position peaked at $2K in Q4 2025.
50 funds tracked by Wall St. Rank held SBC Medical Group as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.